Combined use of interleukin-10 and cyclosporin for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 38/13 (2006.01)

Patent

CA 2228379

A combination of interleukin-10 and cyclosporin is used to suppress graft- versus-host disease, autoimmune diseases and tissue/graft rejection. It has been discovered that administration of a combination of interleukin-10 and cyclosporin causes synergistic suppression of T cell proliferation. Concurrent use of both agents avoids the toxicity associated with higher doses of cyclosporin.

L'invention concerne une combinaison d'interleukine-10 et de cyclosporine pour éviter la réaction de la greffe contre l'hôte, le rejet de la greffe par l'hôte et comme traitement contre les maladies auto-immunes. On a découvert que l'administration d'une combinaison d'interleukine-10 et de cyclosporine a un effet synergique d'inhibition de la prolifération des leucocytes T. L'utilisation simultanée de ces deux agents évite les problèmes de toxicité associés avec des doses plus élevées de cyclosporine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined use of interleukin-10 and cyclosporin for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined use of interleukin-10 and cyclosporin for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of interleukin-10 and cyclosporin for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2069247

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.